Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones

Journal of Cellular Biochemistry

Volumn 61, Issue 3, 1996, Pages 402-409

  Bautista, Diosdado S ^a   Denstedt, John ^b   Chambers, Ann F ^a,b   Harris, John F ^a,b  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

ELISA for urine osteopontin; kidney stones; phenylmethylsulfonyl fluoride; proteolytic cleavage; sialoglycoproteins

Indexed keywords

OSTEOPONTIN; SERINE PROTEINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; URINALYSIS;

ADULT; AGED; BLOTTING, WESTERN; FEMALE; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; OSTEOPONTIN; PROTEASE INHIBITORS; SERINE ENDOPEPTIDASES; SIALOGLYCOPROTEINS;

EID: 0029942138     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960601)61:3<402::AID-JCB7>3.0.CO;2-X     Document Type: Article

References (14)

1. Bautista DS, Xuan JW, Hota C, Chambers AF, Harris JF (1994): Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin. J Biol Chem 269:23280-23285.
2. Berland Y, Dussol B (1994): New insights into renal stone formation. Curr Opinion Nephrol Hypertension, 3:417-423.
3. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW (1993): Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22:147-159.
4. Boyce WH (1968): Organic matrix of human urinary concretions. Am J Med 45:673-683.
5. Denhardt DT, Guo X (1993): Osteopontin: A protein with diverse functions. FASEB J 7:1475-1482.
6. Hunter GK, Kyle CL, Goldberg HA (1994): Modulation of crystal formation by bone phosphoproteins: Structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J 300:723-728.
7. Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi M, Yamate T, Umekawa T, Suzuki Y, Sinohara H, Kurita T (1993): Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180-15184.
8. Nakagawa Y, Abram V, Kezdy FJ, Kaiser ET, Coe FL (1983): Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 256:12594-12600.
9. Nakagawa Y, Netzer M, Coe FL (1990): Immunohistochemical localization of nephrocalcin to proximal tubule and thick ascending limb of Henle's loop of human and mouse kidney: resolution of a conflict. Kidney Int 37:474.
10. Patarca R, Saavedra RA, Cantor H (1993): Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol 13:225-246.
11. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, Hoyer JR (1992): Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426-430.
12. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL (1992): The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 7:1029-1036.
13. Xuan JW, Hota C, Chambers AF (1994): Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion. J Cell Biochem 54:247-255.
14. Yoshida O, Okada Y (1990): Epidemiology of urolithiasis in Japan: A chronological and geographical study. Urol Int 45:104-111.